Results 161 to 170 of about 48,342,326 (223)

Unveiling the comorbidity hub: WT1 drives renal cancer progression in chronic kidney disease and confers sirolimus vulnerability. [PDF]

Exp Ther Med
Zhang W, Tang P, Wu S, Sui Z.
europepmc   +1 more source

A mixed methods study of the impact of WAGR spectrum disorder on individuals and their caregivers. [PDF]

Orphanet J Rare Dis
Sistare EV, George AM, Hathaway ER, Trout KL, Morris J, Krantz SM, Kalish JM.   +6 more
europepmc   +1 more source

Presentación incidental postraumática del tumor de Wilms

Revista Médica Sanitas, 2018
Luis Acosta, Felix Martínez, Luis Ovalle, Pablo Benavidez, Hector Martínez   +4 more
openaire   +1 more source

Convergent IGF2 overexpression in pheochromocytoma/paraganglioma: insights from Beckwith-Wiedemann syndrome. [PDF]

Endocr Relat Cancer
Alkaissi H, Febres-Aldana CA, Talvacchio S, Wang H, Gordon CM, Pacak K.   +5 more
europepmc   +1 more source

Congenital nephrotic syndrome in a newborn with glycogen storage disease and Wilms tumor 1 (WT1) mutation. [PDF]

CEN Case Rep
Annicchiarico Petruzzelli L, De Marco O, Improda N, Giannattasio P, Luongo I, Carucci M, Brunetti B, Serio V, Minale B, Malgieri G.   +9 more
europepmc   +1 more source

Tumor-Associated Macrophage Polarization in Wilms' Tumor After Neoadjuvant Chemotherapy. [PDF]

Cancers (Basel)
Malić Tudor K, Zekić Tomaš S, Dunatov Huljev A, Armanda Bogdan V, Matana A, Ogorevc M, Seiwerth S, Krušlin B, Stepan Giljević J, Kuzmić Prusac I.   +9 more
europepmc   +1 more source

A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies. [PDF]

JCO Clin Cancer Inform
Roy P, Schut I, Graf N, Verschuur A, Chowdhury T, Spreafico F, Brok J, Ramirez-Villar GL, de Camargo B, Godzinski J, Vujanic G, Melchior P, Koolma R, Al-Saadi R, Gessler M, Duncan C, Schenk JP, Furtwängler R, Bonnange HS, Metzger S, Baars D, Pritchard-Jones K, van den Heuvel-Eibrink MM, van Tinteren H.   +23 more
europepmc   +1 more source

H19 and IGF2 imprinting from embryogenesis to oncogenesis. [PDF]

Front Cell Dev Biol
Ortega B, Saeed R, White S, Tajanlangit P, Gallicano GI.   +4 more
europepmc   +1 more source

SNRPC promotes chemoresistance in Wilms tumor via the NF-κB-CXCL17 axis regulating M2-Type TAMs infiltration and targeted nanotherapy research. [PDF]

J Exp Clin Cancer Res
Kong X, Lei L, Jin L, Ren C, Mi T, Wang Q, He D.   +6 more
europepmc   +1 more source

The effect of Wilms tumor 1-associated protein on ferroptosis and immune escape in non-small-cell lung cancer by mediating N6-methyladenosine modification of Twist1. [PDF]

Cytojournal
Yang X, Li J, Li Y, Li M, Peng L, Zhao L, Zou L.   +6 more
europepmc   +1 more source